The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection
Open accessAbstract
BACKGROUND: Reductions in AIDS-related morbidity and mortality following the advent of combination antiretroviral therapy have coincided with relative increases in chronic non-AIDS end-organ diseases among HIV+ patients. OBJECTIVE: To examine the association of latest CD4+ counts with risk of non-AIDS diseases in a cohort of 1397 patients who initiate antiretroviral therapy. METHODS: CD4+ counts and HIV RNA levels along with fatal, and non-fatal, AIDS and non-AIDS diseases (liver, cardiovascular, renal, and cancer) were assessed over a median follow-up of 5 years. Cox proportional regression models were used to study risk associations. RESULTS: A total of 227 patients experienced an AIDS event and 80 patients developed a non-AIDS disease event. Both AIDS and non-AIDS diseases rates (events/100 person-years), respectively, declined with higher latest CD4+ counts: 13.8 and 2.1 with latest CD4+ counts less than 200 cells/microl; 2.0 and 1.7 for counts of 200-350 cells/microl; and 0.7 and 0.7 for counts greater than 350 cells/microl. After adjusting for baseline covariates and the latest HIV RNA level, risk of AIDS and non-AIDS diseases were lowered by 44% (95% confidence interval for hazard ratio 0.50-0.62, P < 0.01) and 14% (95% confidence interval for hazard ratio 0.77-0.96, P = 0.01), respectively, for each 100 cell/microl higher latest CD4+ count. CONCLUSION: Higher CD4+ counts on antiretroviral therapy are associated with lower rates of non-AIDS diseases and AIDS. These findings expand our understanding of the implications of HIV-related immunodeficiency and motivate randomized studies to evaluate the effects of antiretroviral therapy on a broad set of clinical outcomes at CD4+ counts greater than 350 cells/microl.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Castro, K. G., Ward, J. W., Slutsker, L., Buehler, J. W., Jaffe, H. W., Berkelman, R. L., & Curran, J. W. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.4.802 · Cited by 4,349
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
The Statistical Analysis of Failure Time Data
Kalbfleisch, J. D., & Prentice, R. L. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781118032985 · Cited by 3,219
Grulich, A. E., van Leeuwen, M. T., Falster, M. O., & Vajdic, C. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61050-2 · Cited by 2,323
CD4+ Count–Guided Interruption of Antiretroviral Treatment
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,231
The Statistical Analysis of Failure Time Data
Klein, J. P. (1982) · Technometrics · doi:10.1080/00401706.1982.10487769 · Cited by 2,215
Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection
Mellors, J. W., Munoz, A., Giorgi, J. V., Margolick, J. B., Tassoni, C. J., Gupta, P., Kingsley, L. A., Todd, J. A., Saah, A. J., Detels, R., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00003 · Cited by 2,067
Brenchley, J. M., Schacker, T. W., Ruff, L. E., Price, D. A., Taylor, J. H., Beilman, G. J., Nguyen, P. L., Khoruts, A., Larson, M., Haase, A. T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040874 · Cited by 1,832
Autran, B., Carcelain, G., Li, T. S., Blanc, C., Mathez, D., Tubiana, R., Katlama, C., Debré, P., & Leibowitch, J. (1997) · Science · doi:10.1126/science.277.5322.112 · Cited by 1,785
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa030218 · Cited by 1,678
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521
Palella, F. J., Baker, R. K., Moorman, A. C., Chmiel, J. S., Wood, K. C., Brooks, J. T., & Holmberg, S. D. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000233310.90484.16 · Cited by 1,350
Cancer Incidence Before and After Kidney Transplantation
Vajdic, C. M., McDonald, S. P., McCredie, M. R. E., van Leeuwen, M. T., Stewart, J. H., Law, M., Chapman, J. R., Webster, A. C., Kaldor, J. M., & Grulich, A. E. (2006) · JAMA · doi:10.1001/jama.296.23.2823 · Cited by 1,130
Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus: The D:A:D Study
(2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1632 · Cited by 1,113
Association of Cancer With AIDS-Related Immunosuppression in Adults
Frisch, M. (2001) · JAMA · doi:10.1001/jama.285.13.1736 · Cited by 821
The Survival Benefits of AIDS Treatment in the United States
Walensky, R. P., Paltiel, A. D., Losina, E., Mercincavage, L. M., Schackman, B. R., Sax, P. E., Weinstein, M. C., & Freedberg, K. A. (2006) · The Journal of Infectious Diseases · doi:10.1086/505147 · Cited by 581
T Cell Dynamics in HIV-1 Infection
Douek, D. C., Picker, L. J., & Koup, R. A. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141053 · Cited by 571
C-Reactive Protein and the Risk of Incident Colorectal Cancer
Erlinger, T. P. (2004) · JAMA · doi:10.1001/jama.291.5.585 · Cited by 533
Sackoff, J. E., Hanna, D. B., Pfeiffer, M. R., & Torian, L. V. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-6-200609190-00003 · Cited by 451
Palefsky, J. M., Holly, E. A., Efirdc, J. T., Da Costa, M., Jay, N., Berry, J. M., & Darragh, T. M. (2005) · AIDS · doi:10.1097/01.aids.0000181012.62385.4a · Cited by 386
Chin‐Hong, P. V., & Palefsky, J. M. (2002) · Clinical Infectious Diseases · doi:10.1086/344057 · Cited by 313
Mocroft, A., Brettle, R., Kirk, O., Blaxhult, A., Parkin, J. M., Antunes, F., Francioli, P., d'Arminio Monforte, A., Fox, Z., & Lundgren, J. D. (2002) · AIDS · doi:10.1097/00002030-200208160-00012 · Cited by 298
Lack of Mucosal Immune Reconstitution during Prolonged Treatment of Acute and Early HIV-1 Infection
Mehandru, S., Poles, M. A., Tenner-Racz, K., Jean-Pierre, P., Manuelli, V., Lopez, P., Shet, A., Low, A., Mohri, H., Boden, D., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030484 · Cited by 288
Burgi, A., Brodine, S., Wegner, S., Milazzo, M., Wallace, M. R., Spooner, K., Blazes, D. L., Agan, B. K., Armstrong, A., Fraser, S., et al. (2005) · Cancer · doi:10.1002/cncr.21334 · Cited by 234
C-Reactive Protein Is a Marker for Human Immunodeficiency Virus Disease Progression
Lau, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.1.64 · Cited by 212
Highly Active Antiretroviral Therapy and the Epidemic of HIV+ End-Stage Renal Disease
Schwartz, E. J., Szczech, L. A., Ross, M. J., Klotman, M. E., Winston, J. A., & Klotman, P. E. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040340 · Cited by 193
Elevated risk of lung cancer among people with AIDS
Chaturvedi, A. K., Pfeiffer, R. M., Chang, L., Goedert, J. J., Biggar, R. J., & Engels, E. A. (2007) · AIDS · doi:10.1097/qad.0b013e3280118fca · Cited by 166
C REACTIVE PROTEIN IN PATIENTS WITH CHRONIC RENAL DISEASES
Panichi, V., Migliori, M., De Pietro, S., Taccola, D., Bianchi, A. M., Norpoth, M., Metelli, M. R., Giovannini, L., Tetta, C., & Palla, R. (2001) · Renal Failure · doi:10.1081/jdi-100104737 · Cited by 162
The Impact of Cirrhosis on CD4+ T Cell Counts in HIV-Seronegative Patients
McGovern, B., Golan, Y., Lopez, M. J., Pratt, D. S., Lawton, A., Moore, G., Epstein, M., & Knox, T. A. (2007) · Clinical Infectious Diseases · doi:10.1086/509580 · Cited by 144
MacArthur, R. D., Novak, R. M., Peng, G., Chen, L., Xiang, Y., Hullsiek, K. H., Kozal, M. J., van den Berg-Wolf, M., Henely, C., Schmetter, B., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69861-9 · Cited by 139
Self-citationRisk of cancers during interrupted antiretroviral therapy in the SMART study
Silverberg, M. J., Neuhaus, J., Bower, M., Gey, D., Hatzakis, A. E., Henry, K., Hidalgo, J. A. M., Lourtau, L., Neaton, J. D., Tambussi, G., et al. (2007) · AIDS · doi:10.1097/qad.0b013e3282ed6338 · Cited by 137
Self-citationIs there evidence for an increase in the death rate from liver-related disease in patients with HIV?
Mocroft, A., Soriano, V., Rockstroh, J. K., Reiss, P., Kirk, O., Wit, S. D., Gatell, J. M., Clotet, B., Phillips, A. N., & Lundgren, J. D. (2005) · AIDS · doi:10.1097/01.aids.0000194799.43799.ea · Cited by 133
Metabolic and Skeletal Complications of HIV Infection: The Price of Success
Morse, C. G., & Kovacs, J. A. (2006) · JAMA · doi:10.1001/jama.296.7.844 · Cited by 109
Influence of viral hepatitis on HIV infection
Rockstroh, J. K. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.007 · Cited by 98
Decrion-Barthod, A.-Z., Dichamp, I., Varin, A., & Herbein, G. (2005) · Current HIV Research · doi:10.2174/1570162054368057 · Cited by 94
Bini, E. J., Park, J. S., & François, F. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1626 · Cited by 63
MacArthur, R. D., Chen, L., Mayers, D. L., Besch, C. L., Novak, R. M., van den Berg-Wolf, M., Yurik, T. M., Peng, G., Schmetter, B., Brizz, B., et al. (2001) · Controlled Clinical Trials · doi:10.1016/s0197-2456(01)00111-8 · Cited by 35
Self-citation
Cited by
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
The end of AIDS: HIV infection as a chronic disease
Deeks, S. G., Lewin, S. R., & Havlir, D. V. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61809-7 · Cited by 2,063
HIV Infection, Inflammation, Immunosenescence, and Aging
Deeks, S. G. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-042909-093756 · Cited by 1,349
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.
Deeks, S. G., & Phillips, A. N. (2009) · BMJ · doi:10.1136/bmj.a3172 · Cited by 704
Deeks, S. G., Overbaugh, J., Phillips, A., & Buchbinder, S. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.35 · Cited by 644
Metadata
- Authors
- Baker, J. V., Peng, G., Rapkin, J., Abrams, D. I., Silverberg, M. J., MacArthur, R. D., Cavert, W. P., Henry, W. K., & Neaton, J. D.
- Venue
- AIDS
- Published
- 2008-04-23
- Volume
- 22
- Issue
- 7
- Pages
- 841-848
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2005218441
- Cited by
- 372
- References
- 39
- FWCI
- 40.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.